Seattle, WA, United States of America

Kim Folger Bruce

This inventor holds 6 USPTO granted patents, plus 1 CIPO patent. Top assignees: Bristol-Myers Squibb Compnay, Novartis Vaccines & Diagnostics, Gmbh, Oncogen Limited Partnership. Active years: 1996-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kim Folger Bruce. Retrieved from https://idiyas.com/inventor/kim-folger-bruce

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 66.7

 

Average Co-Inventor Count = 4.0

ph-index = 5

Forward Citations = 284(Granted Patents)


Company Filing History:


Years Active: 1996-2012

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Kim Folger Bruce: Innovator in Antibacterial Gene Research

Introduction

Kim Folger Bruce is a prominent inventor based in Seattle, WA (US). She has made significant contributions to the field of antibacterial research, holding a total of 6 patents. Her work focuses on identifying essential genes that play a crucial role in bacterial growth and the development of new antibacterial agents.

Latest Patents

Among her latest patents, Kim has developed methods for generating a database of candidate essential genes. These genes are vital for identifying antibacterial agents suitable for treating and preventing infections. The inventions include methods for confirming the essentiality of candidate genes and utilizing them to screen for new antibacterial drugs. Additionally, her patents encompass the antibacterial agents identified through these methods, along with techniques for their application in treating infections.

Career Highlights

Throughout her career, Kim has worked with notable companies such as Bristol-Myers Squibb Company and Novartis Vaccines & Diagnostics, GmbH. Her experience in these organizations has allowed her to contribute significantly to the advancement of antibacterial research.

Collaborations

Kim has collaborated with esteemed colleagues, including Karl E Hellstrom and George J Schreiber. These partnerships have further enriched her research and innovation in the field.

Conclusion

Kim Folger Bruce is a trailblazer in antibacterial gene research, with a strong portfolio of patents that highlight her innovative contributions. Her work continues to pave the way for new treatments in the fight against bacterial infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…